Go to Page # Page of 27
loading

HERCEPTIN® (Trastuzumab) A Real World Example of Pharmacogenomics – Maximizing Patient Benefit

 Cheryl A. Madsen, RAC
  13th-Aug-2008
Views: 6583
Domain: Medical
Category: Biotech/Pharma
Contents:
HERCEPTIN� (Trastuzumab)
A Real World Example of Pharmacogenomics � Maximizing Patient Benefit

Cheryl A. Madsen, RAC Sr. Manager, Regulatory Affairs Genentech, Inc. July 29, 2004

1

Targeting HER2 in Breast Cancer with Monoclonal Antibodies Herceptin Product Development History HER2 Testing and Patient Selection Pre-approval Diagnostic Strategy Post-approval Diagnostic D ... See more

Recent Presentations

What is Trust Have To Do With Compassion?

Trends of trust in healthcare. Trust needed for conversation between patients & physicians on overuse. Trust should be a core operating principle in health care.

...
21 August, 2019
...
20 August, 2019
Yalin Firinci
19 August, 2019